Stock Events

Medpace 

€319.7
116
-€0.1-0.03% Hoy

Estadísticas

Día Alto
319.7
Día de baja
319.7
52W Alto
-
52W Bajo
-
Volumen
0
Volumen medio
-
Cap. de mercado
9.84B
Relación P/U
33
Rentabilidad por dividendo
-
Dividendo
-

Próximamente

Ganancias

21OctEsperado
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Siguiente
2.31
2.54
2.77
3
GPA esperado
2.5254798961800002
GPA actual
No aplica

La gente también sigue a

Esta lista se basa en las watchlists de personas que siguen a 01P.F en Stock Events. Esto no es una recomendación de inversión.

Competidores

Esta lista es un análisis basado en eventos recientes del mercado. No es una recomendación de inversión.

Acerca de

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
Director general
Dr. August James Troendle M.D.
Empleados
5800
País
US
ISIN
US58506Q1094
WKN
000A2APTV

Listados